Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Earnings Preview For Nov 3 - 7 - Earnings Preview
Oct 31, 2008 10:03 PM
- Analyst Comments: XenoPort, Standard Motor, Vital Images, Ingram Micro, Bank of Ireland, Napster
Sep 19, 2008 10:00 AM
- Analyst Comments: BorgWarner, CarMax, Primedia, Sempra, XenoPort
Jun 23, 2008 12:52 PM
- Periodicals Wrap-Up for Wednesday, June 4th
Jun 04, 2008 10:42 AM
- XenoPort 1Q Loss Widens To $7.3M; Partner GSK Begins Study
May 07, 2008 04:33 PM
- GlaxoSmithKline: Restless Leg Drug Shows Positive Results
Apr 17, 2008 03:39 PM
- GlaxoSmithKline: Restless Leg Drug Shows Positive Results
Apr 17, 2008 03:39 PM
- Analyst Comments: Schering-Plough, Iron Mountain, I-Flow, Regency Centers, XenoPort, EOG Resources, SABESP
Apr 03, 2008 01:43 PM
- Analyst Comments: Genta, XenoPort, Theravance, Palm,
Feb 20, 2008 04:07 AM
- Just a Few Ideas on Markets...
Feb 01, 2008 12:52 AM
- XenoPort Reports Results from a Phase 2 Clinical Trial of XP19986 as a Treatment for the Symptoms of Gastroesophageal Reflux Disease
Dec 02, 2008 07:31 AM
- GSK and XenoPort Announce Plans to Withdraw and Resubmit New Drug Application Requesting Approval of Solzira(TM) for Restless Legs Syndrome
Nov 10, 2008 08:56 AM
- XenoPort to Present at Upcoming Conferences
Nov 06, 2008 11:02 AM
- XenoPort Reports Third Quarter Financial Results
Nov 05, 2008 04:14 PM
- XenoPort to Release Third Quarter Financial Results on November 5, 2008
Oct 17, 2008 02:05 PM
- Zacks Analyst Blog Highlights: Kroger Co., XenoPort, Inc., GlaxoSmithKline Plc., Ltd., Standard Motor Products, Inc. And Vital Images, Inc.
Sep 19, 2008 05:15 PM
- Zacks Analyst Blog Highlights: Kroger Co., XenoPort, Inc., GlaxoSmithKline Plc., Ltd., Standard Motor Products, Inc. And Vital Images, Inc.
Sep 19, 2008 07:07 AM
- GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
Sep 16, 2008 08:04 AM
- XenoPort to Expand Clinical Development of XP19986
Sep 10, 2008 07:09 AM
- XenoPort to Present at the Morgan Stanley Healthcare Conference
Sep 03, 2008 10:32 AM
- Form 4 XENOPORT INC For: Nov 10 Filed by: RIEFLIN WILLIAM JL (10K)
Nov 12, 2008 07:07 PM
- Form 4 XENOPORT INC For: Nov 03 Filed by: Cundy Kenneth C (10K)
Nov 05, 2008 06:14 PM
- Form 4 XENOPORT INC For: Nov 03 Filed by: Gallop Mark A (10K)
Nov 05, 2008 05:18 PM
- Form 4 Gallop Mark A For: Oct 01 (10K)
Oct 03, 2008 05:42 PM
- Form 4 Lofberg Per GH For: Jul 30 (10K)
Sep 17, 2008 07:13 PM
- Form 3 Lofberg Per GH For: Jul 30 (10K)
Sep 17, 2008 07:10 PM
- Form 4 Gallop Mark A For: Sep 12 (10K)
Sep 16, 2008 05:20 PM
- Form 4 XENOPORT INC For: Sep 02 Filed by: Harris William G (10K)
Sep 04, 2008 08:07 PM
- Form 4 XENOPORT INC For: Sep 02 Filed by: Gallop Mark A (10K)
Sep 04, 2008 08:04 PM
- Form 4 XENOPORT INC For: Sep 02 Filed by: Cundy Kenneth C (10K)
Sep 04, 2008 08:04 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
XNPT
|
Compare to S&P
|
| YTD |
-43.74 %
|
-7.82 %
|
| 4 Weeks |
-24.44 %
|
-18.33 %
|
| 12 Weeks |
-34.65 %
|
-9.42 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -95.92 %
|
|
EPS Growth in Last Year: -260.00 %
|
|
Sales Growth in Last Quarter: -57.85 %
|
|
Sales Growth in Last Quarter: -86.27 %
|
|
|
